title: Insufficient therapy for nosocomial meningitis negatively affects survival, sequellae and has social consequences.
authors.forename: M
authors.initials: M
authors.lastname: Huttova
authors.forename: P
authors.initials: P
authors.lastname: Beno
authors.forename: J
authors.initials: J
authors.lastname: Benca
authors.forename: A
authors.initials: A
authors.lastname: Ondrusova
authors.forename: P
authors.initials: P
authors.lastname: Kisac
authors.forename: B
authors.initials: B
authors.lastname: Rudinsky
authors.forename: M
authors.initials: M
authors.lastname: Kovac
authors.forename: F
authors.initials: F
authors.lastname: Bauer
authors.forename: M
authors.initials: M
authors.lastname: Sramka
mesh_terms: D000617:Aminoglycosides / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D015780:Carbapenems / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D003428:Cross Infection / Q000188:drug therapy / Q000401:mortality*; D004359:Drug Therapy, Combination; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D016920:Meningitis, Bacterial / Q000188:drug therapy / Q000401:mortality*; D012189:Retrospective Studies; D017211:Treatment Failure; D014640:Vancomycin / Q000627:therapeutic use; D047090:beta-Lactams / Q000627:therapeutic use
chemical_list: D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; D015780:Carbapenems; D047090:beta-Lactams; D014640:Vancomycin